Retrieve Medical Holdings, Inc. (RMHI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in USD.

Revenue Quarterly

0 40K 80K 120K Q2 '10: 0 Q2 '11: 0 Q4 '14: 117.4K Q1 '15: 0 Q2 '15: 0 Q4 '15: 0 Q1 '16: 0 Q2 '16: 0 Q4 '16: 0 Q1 '17: 0 Q2 '17: 0 Q2 '10 Q4 '14 Q2 '15 Q1 '16 Q4 '16 Q2 '17

Gross Profit Quarterly

0 15K 30K 45K Q4 '14: 44K Q1 '15: 0 Q2 '15: 0 Q4 '15: 0 Q1 '16: 0 Q2 '16: 0 Q4 '16: 0 Q1 '17: 0 Q2 '17: 0 Q4 '14 Q2 '15 Q1 '16 Q4 '16 Q2 '17

Operating Income Quarterly

-120K -80K -40K 0 40K 80K 120K Q1 '18: -8.2K Q2 '18: -3K Q3 '18: -9.6K Q4 '18: -953 Q1 '19: -1.8K Q2 '19: -1.5K Q3 '19: -1.5K Q4 '19: -1.1K Q1 '20: -1.2K Q2 '20: -1.2K Q3 '20: -2K Q4 '20: -5K Q1 '21: -43.2K Q2 '21: -16.8K Q3 '21: -3.7K Q4 '21: -52.1K Q1 '22: -46.6K Q2 '22: -12.1K Q3 '22: -52.6K Q4 '22: -110.4K Q2 '18 Q1 '19 Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22

Net Income Quarterly

-120K -80K -40K 0 40K 80K 120K Q1 '18: -9.4K Q2 '18: -4.3K Q3 '18: -7.1K Q4 '18: -2.9K Q1 '19: -3.6K Q2 '19: -3.7K Q3 '19: -3.8K Q4 '19: -3.5K Q1 '20: -3.5K Q2 '20: -3.6K Q3 '20: -4.4K Q4 '20: -7.4K Q1 '21: -42.7K Q2 '21: -19.2K Q3 '21: -6.8K Q4 '21: -59.4K Q1 '22: -54.6K Q2 '22: 8.8K Q3 '22: -59.9K Q4 '22: -112.2K Q2 '18 Q1 '19 Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22

Cost of Revenue Quarterly

0 60K 120K 180K Q4 '14: 161.4K Q1 '15: 0 Q2 '15: 0 Q4 '15: 0 Q1 '16: 0 Q2 '16: 0 Q4 '16: 0 Q1 '17: 0 Q2 '17: 0 Q4 '14 Q2 '15 Q1 '16 Q4 '16 Q2 '17

Operating Cash Flow Quarterly

-45K -30K -15K 0 15K 30K 45K Q1 '18: -21.4K Q2 '18: -7.1K Q3 '18: -15.1K Q4 '18: -1.5K Q1 '19: -177 Q2 '19: -29 Q3 '19: -31 Q4 '19: -29 Q1 '20: -30 Q2 '20: -30 Q3 '20: -30 Q4 '20: -30 Q1 '21: -30 Q2 '21: -60 Q3 '21: -14.1K Q4 '21: -43.6K Q1 '22: -11.5K Q2 '22: -9.7K Q3 '22: -3.7K Q4 '22: -30.9K Q2 '18 Q1 '19 Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22

Free Cash Flow Quarterly

-450K -300K -150K 0 150K 300K 450K Q2 '15: 35.7K Q3 '15: -38K Q2 '16: -399.9K Q3 '16: -271 Q2 '15 Q3 '15 Q2 '16 Q3 '16

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q2 '12: 220.5M Q4 '12: 220.5M Q1 '13: 330.8M Q2 '13: 330.8M Q4 '13: 60.7M Q1 '14: 67M Q2 '14: 72.5M Q1 '15: 78.4M Q2 '15: 78.4M Q4 '15: 78.4M Q1 '16: 79.8M Q2 '16: 78.4M Q4 '16: 78.4M Q1 '17: 78.4M Q2 '17: 78.4M Q4 '17: 78.4M Q1 '18: 78.4M Q2 '18: 78.4M Q2 '21: 78.4M Q2 '22: 82M Q4 '12 Q4 '13 Q1 '15 Q1 '16 Q1 '17 Q1 '18 Q2 '22

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.04 -0.03 -0.01 0.00 0.01 0.03 0.04 Q3 '13: 0.00 Q4 '13: -0.01 Q1 '14: -0.01 Q2 '14: -0.03 Q3 '18: 0.00 Q4 '18: 0.00 Q1 '19: 0.00 Q2 '19: 0.00 Q3 '19: 0.00 Q4 '19: 0.00 Q1 '20: 0.00 Q2 '20: 0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q1 '22: 0.00 Q2 '22: 0.00 Q4 '13 Q3 '18 Q2 '19 Q1 '20 Q4 '20 Q3 '21 Q2 '22

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.